112 results on '"Uplekar M"'
Search Results
2. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy
3. No universal access to drug-resistant tuberculosis care without engaging all health care providers
4. Sympmed I: Computer Program For Primary Health Care
5. A rapid assessment of prevailing policies on tuberculosis contact investigation
6. Public-private mix for tuberculosis care and prevention. What progress? What prospects?
7. Systematic screening for active tuberculosis: rationale, definitions and key considerations
8. Cash transfer and microfinance interventions for tuberculosis control: Review of the impact evidence and policy implications
9. Study Design
10. Data analysis and reporting
11. Capture-recapture modelling
12. Programmatic approaches to screening for active tuberculosis [State of the art series. Active case finding/screening. Number 6 in the series]
13. A rapid assessment of prevailing policies on tuberculosis contact investigation
14. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications
15. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities
16. Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection
17. Clinical and electrophysiological evaluation of nerve function impairment following cessation of multidrug therapy in leprosy
18. Higher incidence of viableMycobacterium lepraewithin the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy
19. Primary resistance to single and multiple drugs in leprosy-a mouse footpad study
20. Persistence ofMycobacterium lepraein the peripheral nerve as compared to the skin of multidrug-treated leprosy patients
21. The private GP and leprosy: a study
22. The 'vertical-horizontal' debates: time for the pendulum to rest (in peace)?
23. Hard gains through soft contracts: productive engagement of private providers in tuberculosis control.
24. Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh.
25. Viewpoint. Private practitioners and public health: weak links in tuberculosis control.
26. Invest in breaking the barriers of public-private collaboration for improved tuberculosis care.
27. Treatment of tuberculosis: concordance is a key step.
28. Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India.
29. Study Design
30. Capture-recapture modelling
31. Data analysis and reporting
32. Using new TB tools: global rhetoric and ground reality.
33. Tuberculosis makes it onto the international political agenda for health…finally.
34. Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group.
35. Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.
36. What Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?
37. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
38. WHO's End TB Strategy: From stopping to ending the global TB epidemic.
39. Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia.
40. WHO's new end TB strategy.
41. Towards tuberculosis elimination: an action framework for low-incidence countries.
42. Implementing the End TB Strategy: Well begun will be half done.
43. Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.
44. China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data.
45. Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics.
46. Rebalancing the global battle against tuberculosis.
47. Scaling up public-private mix: collaborate or regulate?
48. Systematic screening for active tuberculosis: rationale, definitions and key considerations.
49. Working with workplaces for TB care and control.
50. Global tuberculosis control: lessons learnt and future prospects.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.